IUBMB lifeHumansPrognosisGliomaBiomarkersTumor
LGMN as a Functionally Significant Prognostic and Immunoregulatory Biomarker in Glioma.
Chenyi Nie, Hongsheng Liang, Jiaxin Zhou, Ruiqiang Shang, Hefei Liu, Kuo Li, Zhao Yu, Aili Gao
Published: 202510.1002/iub.70055
Abstract
Studies have shown that Legumain (LGMN) is a potential protease for immunosuppression in glioblastoma multiforme (GBM). Moreover, the elevated expression of LGMN in different types of cancers is linked to an unfavorable prognosis. However, it is stil…
Preview only. Read the full abstract at the source